CM
PACB icon

Caption Management’s Pacific Biosciences PACB Stock Holding History

Caption Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,000
Closed -$11.3K – 1416
2024
Q1 		$11.3K Sell
3,000
-440,100
-99% -$2.58M ﹤0.01% 1116
2023
Q4 		$4.35M Sell
443,100
-505,900
-53% -$4.14M 0.06% 381
2023
Q3 		$7.92M Buy
949,000
+649,000
+216% +$7.42M 0.12% 203
2023
Q2 		$3.99M Buy
+300,000
New +$3.65M 0.07% 337
2022
Q4 		– Sell
-131,400
Closed -$763K – 1603
2022
Q3 		$763K Buy
+131,400
New +$754K 0.01% 958
2022
Q1 		– Sell
-83,300
Closed -$1.71M – 1806
2021
Q4 		$1.71M Sell
83,300
-10,000
-11% -$241K 0.02% 845
2021
Q3 		$2.38M Sell
93,300
-67,500
-42% -$2M 0.03% 695
2021
Q2 		$5.62M Buy
+160,800
New +$4.68M 0.07% 346
2021
Q1 		– Sell
-70,000
Closed -$1.81M – 1298
2020
Q4 		$1.81M Buy
+70,000
New +$1.19M 0.04% 464

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Caption Management's PACB Position: Q2 2024 in Review

Caption Management sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 6,400 shares — an estimated $12.9K sold.

Caption Management first reported a position in PACB in Q3 2019 and held it in 5 quarters. The position peaked at $1.19M in Q3 2023. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Caption Management reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • Caption Management sold 6,400 Pacific Biosciences shares in Q2 2024, an estimated $12.9K.
  • Caption Management first reported a position in Pacific Biosciences in Q3 2019 and held it in 5 quarters.
  • Caption Management's Pacific Biosciences position peaked at $1.19M in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.